Vir Biotechnology VIR
NASDAQ VIR
$10.65 +0.14 (+1.33%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Total Current Liabilities (2018 - 2026)

Updated

Vir Biotechnology (VIR) posted Total Current Liabilities of $94.96 million for Q2 2026, down 9.6% from $105 million a year earlier but up 29.1% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Total Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Vir Biotechnology's Total Current Liabilities came in at $92.82 million, down 22.4% from FY2024.

  • Annual Total Current Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
  • In prior years, Vir Biotechnology's Total Current Liabilities was $119.66 million in FY2024 (-31.8%), $175.41 million in FY2023 (-65.7%), $511.03 million in FY2022 (+49.8%) and $341.24 million in FY2021 (+244.5%).
  • Quarterly Total Current Liabilities has run from a low of $73.56 million in Q1 2026 to a high of $702.36 million in Q1 2022 over five years.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last four quarters, with an average decline of 15.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q4 2021, with growth of 244.5%; the weakest was Q1 2024, with a decline of 80.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $73.56 million (Q1 2026), $92.82 million (Q4 2025) and $75.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Vir Biotechnology 1.78 Bn 1.78 Bn 238.95 Mn 94.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.96 Mn
Mar 31, 2026 73.56 Mn
Dec 31, 2025 92.82 Mn
Sep 30, 2025 75.22 Mn
Jun 30, 2025 105.00 Mn
Mar 31, 2025 137.29 Mn
Dec 31, 2024 119.66 Mn
Sep 30, 2024 117.16 Mn
Jun 30, 2024 96.41 Mn
Mar 31, 2024 94.07 Mn
Dec 31, 2023 175.41 Mn
Sep 30, 2023 165.05 Mn
Jun 30, 2023 225.62 Mn
Mar 31, 2023 485.29 Mn
Dec 31, 2022 511.03 Mn
Sep 30, 2022 308.20 Mn
Jun 30, 2022 477.87 Mn
Mar 31, 2022 702.36 Mn
Dec 31, 2021 341.24 Mn
Sep 30, 2021 233.72 Mn
API Access

Vir Biotechnology Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VIR&period=max&api_key=YOUR_API_KEY